Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
about
Evolving concepts in cancer therapy through targeting sphingolipid metabolismTamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsCeramide induced mitophagy and tumor suppressionThe emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.Acid ceramidase is upregulated in AML and represents a novel therapeutic target.Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemiaSphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide.Sphingolipid metabolism in cancer signalling and therapy.Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression.STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemiaVaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study
P2860
Q26863646-977A608D-970F-4BDE-941D-7493BA218949Q28084270-5068F937-07F2-4C94-ACE4-3001D495FFE2Q28384389-4CBC2915-FEDB-4761-8E57-EA9A2BA2A90AQ30252512-2C186202-2490-4D7C-AEC8-F1F55F6916F4Q30275460-FE847BB3-1EB7-437A-A3AE-B099E97DDC17Q30276873-B339A357-31BC-4A0B-BA81-6CF87B7EE442Q30278883-EC2AD9EB-18C1-48D0-A0BE-A4841C2BE827Q30300370-1D90D49A-BA60-4CBD-A01D-31EEB8C8A6E9Q38495744-5DAB2631-FC57-4DA2-97A8-C89B11AA6F77Q38793821-D0D9C653-7733-41EA-9982-81CE230313C2Q46269345-30C0DD15-F545-477E-9673-9BB3B2FF8B99Q49950035-3709C8FF-FB9F-463D-9355-CA0D1AC7D540Q50058499-5139CF57-F1C7-46F4-BB54-61D95F1B2613Q52716419-B797D2E6-E471-404C-BA9B-129C18C00FECQ54943815-E7CB02C1-91CF-4025-92A8-97B3B9412B77Q56481251-73F47C07-2C98-424F-B229-4FEE81D0CB2AQ58722987-2B3785B6-4BDA-440B-95D0-D937AB9F7F70
P2860
Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@ast
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@en
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@nl
type
label
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@ast
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@en
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@nl
prefLabel
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@ast
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@en
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@nl
P2093
P2860
P50
P1433
P1476
Targeting glucosylceramide syn ...... natural killer cell leukemia.
@en
P2093
Jason Liao
Kathleen Broeg
Myles C Cabot
Sriram Shanmugavelandy
Thomas P Loughran
Todd E Fox
P2860
P304
P356
10.3109/10428194.2012.752485
P577
2012-12-31T00:00:00Z